Literature DB >> 24425107

Transforming growth factor beta1 (TGFβ1) polymorphisms and breast cancer risk.

Davar Amani1, Ahad Khalilnezhad, Abbas Ghaderi, Norrio Niikawa, Ko-ichiro Yoshiura.   

Abstract

Transforming growth factor β1 (TGFβ1) is suggested to be involved in the pathogenesis of and in complications with breast cancer (BC). Polymorphisms in TGFβ1 gene (TGFβ1) have been suggested by many investigators to have a role in susceptibility to BC; however, many discordant data have been reported. Considering the role of ethnic variations, we performed an association study between TGFβ1 polymorphisms and BC among Iranian women. We sequenced DNA samples of 110 BC and 110 normal control women for the exons and their adjacent intronic regions of TGFβ1 using PCR. The allele, genotype, and haplotype frequencies were calculated using PowerMarker V3.25 and R 3.0.2 softwares. Ten single nucleotide polymorphisms (SNPs) were detected. Statistical analysis on the frequency of seven most frequent SNPs, including the three coding SNPs (cSNPs) revealed no significant difference between BC and control women. Moreover, among 11 constructed haplotypes, "GTGCCGC" was significantly different between two study groups. In conclusion, we found no association between the studied SNPs of TGFβ1 and BC among Iranian women, but a possible association between "GTGCCGC" haplotype and BC was seen. However, further studies are suggested to clarify this association.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24425107     DOI: 10.1007/s13277-014-1621-x

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  55 in total

Review 1.  TGF-beta signaling in mammary gland development and tumorigenesis.

Authors:  L M Wakefield; E Piek; E P Böttinger
Journal:  J Mammary Gland Biol Neoplasia       Date:  2001-01       Impact factor: 2.673

2.  Evidence of association and linkage disequilibrium between a novel polymorphism in the transforming growth factor beta 1 gene and hip bone mineral density: a study of female twins.

Authors:  R W Keen; H Snieder; H Molloy; J Daniels; M Chiano; F Gibson; L Fairbairn; P Smith; A J MacGregor; D Gewert; T D Spector
Journal:  Rheumatology (Oxford)       Date:  2001-01       Impact factor: 7.580

3.  Association of a TGF-β1 gene -509 C/T polymorphism with breast cancer risk: a meta-analysis.

Authors:  Sang Uk Woo; Kyong Hwa Park; Ok Hee Woo; Dae Sik Yang; Ae-Ree Kim; Eun Sook Lee; Jae-Bok Lee; Yeul Hong Kim; Jun Suk Kim; Jae Hong Seo
Journal:  Breast Cancer Res Treat       Date:  2010-04-02       Impact factor: 4.872

4.  Intron-exon structure of the human transforming growth factor-beta precursor gene.

Authors:  R Derynck; L Rhee; E Y Chen; A Van Tilburg
Journal:  Nucleic Acids Res       Date:  1987-04-10       Impact factor: 16.971

5.  Combined genetic assessment of transforming growth factor-beta signaling pathway variants may predict breast cancer risk.

Authors:  Virginia G Kaklamani; Lisa Baddi; Junjian Liu; Diana Rosman; Sharbani Phukan; Ciarán Bradley; Chris Hegarty; Bree McDaniel; Alfred Rademaker; Carole Oddoux; Harry Ostrer; Loren S Michel; Helen Huang; Yu Chen; Habibul Ahsan; Kenneth Offit; Boris Pasche
Journal:  Cancer Res       Date:  2005-04-15       Impact factor: 12.701

6.  Polymorphisms in the transforming growth factor beta 1 gene and osteoporosis.

Authors:  Bente Lomholt Langdahl; Mette Carstens; Liselotte Stenkjaer; Erik Fink Eriksen
Journal:  Bone       Date:  2003-03       Impact factor: 4.398

Review 7.  Global trends in breast cancer incidence and mortality.

Authors:  Peggy L Porter
Journal:  Salud Publica Mex       Date:  2009

8.  T29C polymorphism in the transforming growth factor beta1 gene and postmenopausal breast cancer risk: the Multiethnic Cohort Study.

Authors:  Loïc Le Marchand; Christopher A Haiman; David van den Berg; Lynne R Wilkens; Laurence N Kolonel; Brian E Henderson
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2004-03       Impact factor: 4.254

9.  TGF-beta1 genotype and phenotype in breast cancer and their associations with IGFs and patient survival.

Authors:  L Mu; D Katsaros; L Lu; M Preti; A Durando; R Arisio; H Yu
Journal:  Br J Cancer       Date:  2008-09-30       Impact factor: 7.640

10.  TGFB1 and TGFBR1 polymorphisms and breast cancer risk in the Nurses' Health Study.

Authors:  David G Cox; Kathryn Penney; Qun Guo; Susan E Hankinson; David J Hunter
Journal:  BMC Cancer       Date:  2007-09-11       Impact factor: 4.430

View more
  5 in total

Review 1.  Association of genetic polymorphisms with osteosarcoma risk: a meta-analysis.

Authors:  Zhenyu Bian; Qifang He; Xuepeng Wang; Maoqiang Li; Liulong Zhu
Journal:  Int J Clin Exp Med       Date:  2015-06-15

2.  Gene expression profiling of the 8q22-24 position in human breast cancer: TSPYL5, MTDH, ATAD2 and CCNE2 genes are implicated in oncogenesis, while WISP1 and EXT1 genes may predict a risk of metastasis.

Authors:  Afsoon Taghavi; Mohammad Esmaeil Akbari; Mohammad Hashemi-Bahremani; Nahid Nafissi; Ahad Khalilnezhad; Seyed Mohammad Poorhosseini; Feyzollah Hashemi-Gorji; Vahid Reza Yassaee
Journal:  Oncol Lett       Date:  2016-09-30       Impact factor: 2.967

3.  Polymorphisms of -800G/A and +915G/C in TGF-β1 gene and lung cancer susceptibility.

Authors:  Qing-Guo Di; Bao-Hua Sun; Ming-Ming Jiang; Jun-Feng Du; Zhi-Tao Mai; Xin Zhang; Li-Rong Zhou; Yu-Min Chi; Jing Lv
Journal:  Oncol Lett       Date:  2017-05-16       Impact factor: 2.967

Review 4.  Genetic and molecular biology of breast cancer among Iranian patients.

Authors:  Meysam Moghbeli
Journal:  J Transl Med       Date:  2019-07-08       Impact factor: 5.531

Review 5.  Two faces of TGF-beta1 in breast cancer.

Authors:  Joanna Magdalena Zarzynska
Journal:  Mediators Inflamm       Date:  2014-05-07       Impact factor: 4.711

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.